市场调查报告书
商品编码
1354303
远端病理学市场规模 - 按产品(扫描器、通讯系统、储存系统)、按应用(远端会诊、药物发现、疾病诊断)、按最终用途(医院、学术和研究机构) - 到 2032 年的全球预测Telepathology Market Size - By Product (Scanner, Communication System, Storage System), By Application (Teleconsultation, Drug Discovery, Disease Diagnosis), By End-use (Hospitals, Academic & Research Institutes) - Global Forecast to 2032 |
2023 年至 2032 年,全球远距病理市场规模将以 12.4% 的复合年增长率成长。
VR(虚拟实境)和 AR(扩增实境)应用程式的持续实验和开发,旨在增强数位病理影像的可视化和交互,为病理学家提供更身临其境的体验,这将促进市场成长。 AR 和 VR 技术在增强病理学家能力方面的发展提高了诊断准确性,最终有利于病患照护。
整个远距病理学市场根据产品、应用、最终用途和地区分为两部分。
从产品来看,2023-2032年通讯系统产业价值复合年增长率将达12.8%。远距病理通讯系统和技术使病理学家和医疗专业人员能够远端协作、分享专业知识并提供及时的诊断和咨询。一些医疗机构和公司还提供专门的远距病理咨询平台,用于整合各种通讯和诊断工具,以简化远距病理流程。即时视讯会议工具的涌入使病理学家和专家能够分享见解和讨论病例,也将有利于该细分市场的成长。
就应用而言,到 2032 年,药物发现领域的远端病理学市场规模预计将增长 12.3%。这一增长可归因于远端病理学在简化和加速药物发现流程、同时促进高效资料共享方面的重要性日益提高。协作以及远端专业知识利用。重大技术进步将进一步推动远距病理学在药物研发工作中的采用。
从地区来看,由于人们日益关注加强偏远地区的医疗保健服务,预计到 2032 年,亚太地区远距病理学产业的复合年增长率将超过 13%。该地区的一些政府正在提出远距病理学倡议,以改善获得病理服务的机会。举个例子,2022年1月,印度发起「Heal in India」倡议,以促进医疗旅游业的成长。不断发展的远距病理服务监管框架也将促进区域市场的成长。
Global telepathology market size will expand at 12.4% CAGR from 2023-2032.
The rising experimentation and development of VR (virtual reality) and AR (augmented reality) applications for enhancing the visualization and interaction with digital pathology images to render more immersive experience for pathologists will add to the market growth. The evolution of AR and VR technologies in enhancing the capabilities of pathologists has led to enhanced diagnostic accuracy, ultimately benefiting patient care.
The overall telepathology market is bifurcated based on product, application, end-use and region.
Based on product, the industry value from communication system will register 12.8% CAGR from 2023-2032. Telepathology communication systems and technologies enable pathologists and medical professionals to remotely collaborate, share expertise, and offer timely diagnoses and consultations. Several healthcare institutions and companies are also offering specialized telepathology consultation platforms for integrating various communication and diagnostic tools to streamline the telepathology process. The influx of real-time video conferencing tools to enable pathologists and specialists to share insights and discuss cases will also prove favorable for the segment growth.
With respect to application, the telepathology market size from the drug discovery segment is slated to observe 12.3% rate up to 2032. The growth can be attributed to the rising importance of telepathology in streamlining and accelerating the drug discovery processes while facilitating efficient data sharing, collaboration as well as remote expertise utilization. The significant technology advances will further drive the adoption of telepathology in pharmaceutical R&D efforts.
Regionally, the Asia Pacific telepathology industry is expected to witness over 13% CAGR through 2032 due to the surging focus on enhancing healthcare access in remote areas. Several governments in the region are coming up with telepathology initiatives for improving access to pathology services. To cite an instance, in January 2022, the 'Heal in India' initiative was launched in India to boost the medical tourism growth. The evolving regulatory frameworks for telepathology services will also add to the regional market growth.